Vitamin A (Retinol): What Your Number Changes About Your Treatment

At a glance
- Normal serum retinol / 20 to 60 mcg/dL (0.70 to 2.09 µmol/L)
- Deficiency threshold / below 20 mcg/dL (0.70 µmol/L)
- Toxicity concern / above 100 mcg/dL or symptomatic above 60 mcg/dL
- Global deficiency prevalence / approximately 190 million preschool children and 19 million pregnant women worldwide
- Teratogenic dose / above 10 to 000 IU per day linked to birth defects
- Isotretinoin interaction / do not co-supplement vitamin A during treatment
- Liver storage / 80 to 90 percent of total body vitamin A is stored in the liver
- Fasting required / a 12-hour fast is recommended before testing for accuracy
- Retest interval / 8 to 12 weeks after corrective supplementation or dose change
What Serum Retinol Actually Measures
Serum retinol reflects the circulating concentration of preformed vitamin A bound to retinol-binding protein (RBP). This value does not directly measure liver stores, which hold 80 to 90% of total body vitamin A [1]. Instead, serum retinol is homeostatically regulated: liver reserves must drop significantly before the blood level falls, and they must become saturated before the blood level climbs above normal.
This is why the test has a clinical blind spot. A person with mildly depleted liver stores can still show a "normal" serum retinol of 30 mcg/dL. The World Health Organization classifies serum retinol below 0.70 µmol/L (20 mcg/dL) as deficient and below 0.35 µmol/L (10 mcg/dL) as severely deficient [2]. On the high end, values persistently above 60 mcg/dL with supplementation history warrant investigation for chronic hypervitaminosis A, which carries hepatotoxic risk even when symptoms are subtle [3].
For prescribing decisions, context matters more than the number alone. Your clinician will interpret your retinol result alongside liver enzymes (ALT, AST), kidney function, lipid panels, pregnancy status, and your current medication list. A retinol of 55 mcg/dL means something different in a patient about to start isotretinoin than in someone with no retinoid exposure.
Normal Vitamin A (Retinol) Range and What Shifts It
Most clinical laboratories define the adult reference interval as 20 to 60 mcg/dL (0.70 to 2.09 µmol/L), though some use a narrower upper bound of 49 mcg/dL [4]. Children and adolescents have slightly different ranges depending on age and sex.
Several non-pathological factors can shift your number. Alcohol consumption reduces hepatic retinol storage and can lower serum levels by 15 to 30% in heavy drinkers [5]. Oral contraceptives tend to raise retinol levels modestly. Pregnancy redistributes vitamin A to the fetus, often dropping maternal serum retinol in the third trimester. A high-fat meal within 12 hours of the blood draw can transiently raise retinyl esters in the sample, which is why fasting specimens are standard.
Certain medications also interfere. Orlistat, prescribed for weight management alongside GLP-1 agonists in some protocols, reduces fat-soluble vitamin absorption by roughly 30% [6]. Cholestyramine and other bile acid sequestrants have a similar effect. If you take any of these, your provider may order retinol levels at baseline and periodically during treatment.
What a High Vitamin A (Retinol) Level Means
A serum retinol above 60 mcg/dL, especially above 100 mcg/dL, raises the question of hypervitaminosis A. Acute toxicity occurs with single massive doses (above 660 to 000 IU in adults), but chronic toxicity is the more common clinical scenario. It develops with sustained intake above 25 to 000 IU per day over weeks to months [7].
Symptoms of chronic hypervitaminosis A include persistent headache, dry and peeling skin, alopecia, bone pain, hepatomegaly, and elevated liver transaminases. The National Institutes of Health Office of Dietary Supplements sets the tolerable upper intake level (UL) at 10 to 000 IU per day for adults [8]. Exceeding this threshold does not guarantee toxicity, but it substantially increases risk.
The treatment implications of a high retinol level are direct. Isotretinoin (Accutane) is itself a vitamin A derivative (13-cis-retinoic acid). Prescribing it to someone with an already elevated retinol level compounds the risk of pseudotumor cerebri (idiopathic intracranial hypertension), a condition marked by severe headaches and vision changes [9]. The iPLEDGE program does not mandate pre-treatment retinol levels, but many dermatologists check them anyway because the clinical consequence of missing hypervitaminosis A in this population is serious.
How to Lower Vitamin A
Reducing a high retinol level is straightforward in most cases. Stop supplementation. Preformed vitamin A (retinyl palmitate, retinyl acetate) is the usual culprit, found in multivitamins, liver-based supplements, and cod liver oil. Beta-carotene from plant sources does not cause hypervitaminosis A because its conversion to retinol is regulated by feedback mechanisms [10].
After discontinuing excess supplementation, recheck serum retinol in 8 to 12 weeks. Liver stores deplete slowly, so levels may take 2 to 6 months to normalize fully. If transaminases are elevated, your provider will likely order repeat liver function tests at the same interval. Persistent elevation despite supplementation cessation warrants hepatology referral to rule out hepatic fibrosis from chronic vitamin A overload.
What a Low Vitamin A (Retinol) Level Means
A retinol below 20 mcg/dL indicates deficiency. The WHO estimates that vitamin A deficiency affects approximately 190 million preschool-age children and 19.1 million pregnant women globally, with highest prevalence in sub-Saharan Africa and South Asia [2]. In the United States, clinical deficiency is uncommon but subclinical insufficiency is underdiagnosed, particularly in patients with malabsorptive conditions.
The earliest clinical sign is night blindness (nyctalopia), which can develop at retinol levels between 10 and 20 mcg/dL. Prolonged deficiency leads to xerophthalmia, Bitot spots on the conjunctiva, and eventually corneal ulceration. Beyond ocular effects, vitamin A deficiency impairs epithelial barrier integrity, reducing mucosal immunity. A Cochrane review of 43 trials (N = 215,633 children) found that vitamin A supplementation reduced all-cause mortality by 24% (RR 0.76 to 95% CI 0.69 to 0.83) in children aged 6 months to 5 years in deficiency-endemic areas [11].
Common causes of low retinol in the telehealth population include bariatric surgery (especially Roux-en-Y gastric bypass), celiac disease, Crohn disease with ileal involvement, chronic pancreatitis, cholestatic liver disease, and prolonged use of fat-absorption-blocking medications like orlistat.
How to Raise Vitamin A
For mild deficiency (retinol 10 to 20 mcg/dL), oral supplementation with 10,000 to 25 to 000 IU of preformed vitamin A daily for 1 to 2 weeks, followed by a maintenance dose of 5,000 to 10 to 000 IU daily, is a standard repletion protocol. The WHO recommends a single high-dose supplement of 200 to 000 IU for severely deficient adults, repeated at 4 to 6 months [12]. Dietary sources rich in preformed vitamin A include beef liver (one 3-ounce serving provides roughly 6 to 580 mcg RAE, or 21 to 900 IU), dairy products, and eggs.
For patients with malabsorption, water-miscible vitamin A preparations are better absorbed than oil-based formulations. Co-administration with dietary fat (at least 3 to 5 grams) improves absorption of standard preparations. Recheck serum retinol 8 to 12 weeks after starting supplementation.
How Vitamin A Levels Affect Specific Treatments
Isotretinoin and Retinoid Therapy
Isotretinoin's prescribing information explicitly warns against concurrent vitamin A supplementation due to additive toxicity [9]. Before starting isotretinoin 0.5 to 1 mg/kg/day, clinicians should confirm the patient is not taking supplemental vitamin A above the RDA (900 mcg RAE for men, 700 mcg RAE for women). A baseline retinol level above 60 mcg/dL should prompt investigation and correction before initiation. During treatment, routine retinol monitoring is not standard, but any new-onset headache or visual changes warrants urgent evaluation for pseudotumor cerebri.
Topical retinoids (tretinoin, adapalene, tazarotene) do not significantly affect serum retinol and do not require blood monitoring.
Hormone Replacement Therapy
Vitamin A interacts with estrogen metabolism in ways that have prescribing relevance. Estrogen-containing HRT increases circulating retinol-binding protein, which raises serum retinol levels [13]. A woman on combined estrogen-progestogen therapy may show a retinol of 55 mcg/dL that would be 40 mcg/dL off therapy. This is a pharmacokinetic artifact, not true hypervitaminosis A, and does not typically require intervention.
The clinical exception is the woman on HRT who is also taking supplemental vitamin A. The combination of estrogen-driven RBP elevation plus exogenous retinol intake can push levels into the genuinely toxic range. Clinicians prescribing HRT should ask about supplement use and check retinol if the patient reports symptoms consistent with hypervitaminosis A (skin peeling, new headaches, joint pain).
For testosterone replacement therapy (TRT), the interaction is less direct. Animal data suggest that vitamin A supports Sertoli cell function and spermatogenesis [14], but there is no established clinical threshold below which TRT outcomes worsen. Clinicians do not routinely order retinol levels before starting TRT. If a patient on TRT has concurrent dermatologic complaints or plans to use isotretinoin for acne (a common TRT side effect), retinol testing becomes relevant.
GLP-1 Receptor Agonists and Weight Loss Medications
Rapid weight loss from semaglutide, tirzepatide, or bariatric surgery can deplete fat-soluble vitamin stores. In the STEP-1 trial (N = 1,961), participants on semaglutide 2.4 mg lost a mean of 14.9% body weight at 68 weeks [15]. While STEP-1 did not report micronutrient outcomes, the mechanism parallels bariatric surgery, where vitamin A deficiency prevalence ranges from 10 to 69% depending on procedure type and follow-up duration [16].
The American Society for Metabolic and Bariatric Surgery (ASMBS) guidelines recommend monitoring fat-soluble vitamins (A, D, E, K) after bariatric procedures, with retinol checked at baseline, 6 months, and annually thereafter [17]. No equivalent guideline exists specifically for GLP-1-induced weight loss, but the biochemical rationale for monitoring is similar when patients lose more than 15% of body weight. Clinicians managing patients on semaglutide or tirzepatide who have concurrent orlistat use, pancreatic insufficiency, or pre-existing malabsorption should consider adding retinol to their monitoring panel.
Liver-Metabolized Medications
Because the liver stores and processes vitamin A, any medication with hepatotoxic potential creates a compounding risk when retinol levels are high. Methotrexate, used for autoimmune conditions and sometimes co-prescribed alongside hormone therapy, is hepatotoxic at cumulative doses [18]. A patient on methotrexate with a retinol of 80 mcg/dL has two concurrent hepatic stressors. The same logic applies to patients on high-dose acetaminophen or chronic alcohol use alongside elevated retinol.
The clinical action is to measure retinol at baseline in patients starting hepatotoxic medications and to address any elevation before the drug is introduced. The American College of Gastroenterology does not include retinol in standard hepatotoxicity monitoring panels, so clinicians must remember to add it selectively.
When to Retest and What to Track Alongside Retinol
Retinol alone provides an incomplete picture. A comprehensive assessment pairs it with retinol-binding protein (RBP4), hepatic function markers (ALT, AST, GGT), and a review of supplement intake. In inflammatory states, serum retinol drops as an acute-phase response regardless of true vitamin A status, because inflammation reduces RBP synthesis [19]. C-reactive protein (CRP) measured on the same draw helps distinguish true deficiency from inflammation-driven suppression.
Retest timing depends on the clinical scenario. After starting or stopping supplementation, allow 8 to 12 weeks. After bariatric surgery, check at 3 months, 6 months, and annually. After discontinuing isotretinoin, retinol normalization is not a concern because isotretinoin itself does not raise retinol (it is a distinct retinoid metabolite). Patients on estrogen-containing therapies who show borderline-high retinol should have a repeat level 6 to 8 weeks after any supplement adjustment.
The threshold for clinical action is context-dependent, but a reasonable framework: retinol below 20 mcg/dL, supplement and recheck. Retinol 20 to 60 mcg/dL, no action unless starting a retinoid medication. Retinol above 60 mcg/dL, investigate supplement use, check liver enzymes, and hold any planned retinoid prescriptions until the level normalizes. Retinol above 100 mcg/dL with symptoms, stop all vitamin A sources immediately and consider hepatology referral. A baseline retinol is reasonable for any patient starting isotretinoin, high-dose vitamin A supplementation, or a weight-loss protocol expected to exceed 15% total body weight loss.
Frequently asked questions
›What is a normal Vitamin A (retinol) level?
›What does a high Vitamin A (retinol) mean?
›What does a low Vitamin A (retinol) mean?
›Can I take vitamin A while on isotretinoin?
›Does GLP-1 medication affect my vitamin A level?
›Should I take vitamin A supplements if my level is normal?
›How long does it take for vitamin A levels to change?
›Does hormone therapy affect vitamin A levels?
›Can too much vitamin A cause liver damage?
›Is beta-carotene safer than preformed vitamin A?
›What foods are highest in vitamin A?
›Do I need to fast before a vitamin A blood test?
References
- Blaner WS, Li Y, Brun PJ, et al. Vitamin A absorption, storage and mobilization. Subcell Biochem. 2016;81:95-125. https://pubmed.ncbi.nlm.nih.gov/27830502/
- World Health Organization. Global prevalence of vitamin A deficiency in populations at risk 1995-2005: WHO global database on vitamin A deficiency. Geneva: WHO; 2009. https://www.who.int/publications/i/item/9789241598019
- Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr. 2006;83(2):191-201. https://pubmed.ncbi.nlm.nih.gov/16469975/
- Mayo Clinic Laboratories. Vitamin A, serum. Test ID: VITA. https://www.ncbi.nlm.nih.gov/books/NBK557456/
- Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr. 1999;69(6):1071-1085. https://pubmed.ncbi.nlm.nih.gov/10357725/
- McDuffie JR, Calis KA, Booth SL, et al. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy. 2002;22(7):814-822. https://pubmed.ncbi.nlm.nih.gov/12126214/
- Hathcock JN, Hattan DG, Jenkins MY, et al. Evaluation of vitamin A toxicity. Am J Clin Nutr. 1990;52(2):183-202. https://pubmed.ncbi.nlm.nih.gov/2197848/
- National Institutes of Health Office of Dietary Supplements. Vitamin A and carotenoids: fact sheet for health professionals. Updated 2024. https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/
- U.S. Food and Drug Administration. Accutane (isotretinoin) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s064lbl.pdf
- Tang G. Bioconversion of dietary provitamin A carotenoids to vitamin A in humans. Am J Clin Nutr. 2010;91(5):1468S-1473S. https://pubmed.ncbi.nlm.nih.gov/20200262/
- Imdad A, Mayo-Wilson E, Herzer K, Bhutta ZA. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2022;3(3):CD008524. https://pubmed.ncbi.nlm.nih.gov/35294044/
- World Health Organization. Vitamin A supplementation in infants and children 6-59 months of age. Geneva: WHO; 2011. https://www.who.int/publications/i/item/9789241501767
- Formelli F, Carsana R, Costa A, et al. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients. Cancer Res. 1989;49(21):6149-6152. https://pubmed.ncbi.nlm.nih.gov/2790828/
- Hogarth CA, Griswold MD. The key role of vitamin A in spermatogenesis. J Clin Invest. 2010;120(4):956-962. https://pubmed.ncbi.nlm.nih.gov/20364093/
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Ledoux S, Calabrese D, Bogard C, et al. Long-term evolution of nutritional deficiencies after gastric bypass. Ann Surg. 2020;271(2):e38-e40. https://pubmed.ncbi.nlm.nih.gov/31356276/
- Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures. Surg Obes Relat Dis. 2020;16(2):175-247. https://pubmed.ncbi.nlm.nih.gov/31917200/
- Visser K, van der Heijde D. Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis. Clin Exp Rheumatol. 2009;27(6):1017-1025. https://pubmed.ncbi.nlm.nih.gov/20149325/
- Thurnham DI, McCabe GP, Northrop-Clewes CA, Nestel P. Effects of subclinical infection on plasma retinol concentrations and assessment of prevalence of vitamin A deficiency. Lancet. 2003;362(9401):2052-2058. https://pubmed.ncbi.nlm.nih.gov/14697804/